Navigation Links
Abraxis in Medical News

Life Beyond Cancer Women's Retreat Calls for Applications

...ry resort in Catalina, Ariz., is offered at an extremely affordable cost thanks to many sponsors including Platinum Sponsor Eisai , Gold Sponsors abraxis Oncology and Miraval luxury resort, Silver Sponsor James Lasker, MD , and contributor BAG IT , but space is extremely limited. Deadline fo...

Drug May Extend Life When Breast Cancer Spreads

...gs known as taxanes. The study, which was a phase 2 trial, was funded by abraxis BioScience, which makes Abraxane. The findings are reported in the May 26 i..." Gradishar, who was the lead author for the study, is also a consultant to abraxis BioScience. The chemotherapy drugs docetaxel, marketed as Taxotere, and ...

RAND Launches Unique Tool to Evaluate Health Care Proposals

...s, corporations, corporate foundations, philanthropic foundations, and health system stakeholders. To date, funders include the following: AARP; abraxis BioScience, Patrick Soon-Shiong, MD, Founder, Chairman, and CEO; Aetna Foundation; Alcoa; Amgen Foundation; Blue Cross Blue Shield of Massachusetts; C...

Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City

...rvices at Memorial Sloan-Kettering Cancer Center, founded MBCN. MBCN is supported in part through charitable contributions from many sources including abraxis BioScience and AstraZeneca. Conference Information: Date: Saturday, October 13, 2007 Location: NYU Medical Center, 401 East 30 Street, between...
Abraxis in Medical Technology

Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response

... LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, glo...ith bevacizumab as an effective antitumor agent. abraxis continues to explore the role of nab-technology fo... About nab(TM) Technology Platform Developed by abraxis BioScience, nanoparticle albumin-bound (nab(TM)) t...

Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway

... LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, glo...ive, head-and-neck cancer patients (25 percent). abraxis continues to explore the role of nab-technology fo... About nab(TM) Technology Platform Developed by abraxis BioScience, nanoparticle albumin-bound (nab(TM)) t...

Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycin's Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway

... LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, glo...e role of mTOR inhibition has led investigators at abraxis to explore the use of the nanoparticle albumin-bou...se I clinical trials with nab-rapamycin in 2007. abraxis continues to explore the role of nab technology fo...
Abraxis in Biological News

2 new therapies show promise for cancer patients

... in pancreatic cancer specimens. The SPARC protein is being investigated by abraxis BioScience in this trial as a potential target for nab-paclitaxel. A test for SPARC, developed at abraxis and Caris MPI and applied by Caris MPI under contract with Abraxis, was uti...

Nanoparticle Breast Cancer Drug Approved by FDA

... be due to preferential delivery of albumin-bound paclitaxel to cancer cells. Abraxane was developed by American Bioscience and will be marketed by abraxis Oncology, a division of American Pharmaceutical Partners. ...
Abraxis in Biological Technology

UCLA welcomes startup to new incubator space at California NanoSystems Institute

...r. Patrick Soon-Shiong, a UCLA visiting professor of bioengineering and of microbiology, immunology and molecular genetics and founder and chairman of abraxis BioScience, a founding partner of the CNSI. ...

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... highly fragmented and is characterized by the presence of several key and niche players. Major market participants in the nanomedicine market include abraxis BioScience Inc., AMAG Pharmaceuticals Inc, Arrowhead Research Corporation, Crucell N.V., Flamel Technologies S.A., Elan Corporation Plc, Enzon Pharmac...

Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research

...ects of nab-rapamycin (ABI-009) in combination with kinase inhibitors Erlotinib and Perifosine Author(s): Neil Desai, Osmond D'Cruz, Vuong Trieu. abraxis BioScience, LLC., Los Angeles, CA Time/location: 1:00 PM - 5:00 PM, Hall B-F, Poster Section 33, # 9 Abstract Summary: According to Investiga...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... SNTA ) ZYMOGENETICS INC (NASDAQ: ZGEN ) Add abraxis BIOSCIENCE INC (NASDAQ: ABII ) CHUGAI PHARM CO (...EL HOLDING AG-REG (SWX, Switzerland: SPPN) Add abraxis BIOSCIENCE INC (NASDAQ: ABII ) BIOMARIN PHARMACE...NASDAQ: SIAL ) WATERS CORP (NYSE: WAT ) Add abraxis BIOSCIENCE INC NEW (NASDAQ: ABII ) AMERISOURCEBE...

Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium

...asense(R) (oblimersen sodium) Injection in combination with Abraxane(R) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound; abraxis BioScience, Inc.) and Temodar(R) (temozolomide; Schering Plough, Inc.) in patients with advanced metastatic melanoma. The study represents the rapid t...

2006: A mixed blessing for Midwest life science companies

... Missouri $77.72 $63.32 +23% $5.2 18. abraxis Bioscience (ABBI) Illinois $27.34 $38.63 ...Laggards - 2006 Company, % Decline 1. abraxis Bioscience, 2. St. Jude Medical, 3. H...w business from a number of hospital groups. abraxis Bioscience suffered, in spite of the successful ...

Midwest life science stocks sizzle in a tepid first quarter

... $6.4 17. Sigma-Aldrich (SIAL) $41.52 $39.21 +6% $5.5 18. abraxis Bioscience (ABBI) $26.71 $27.60 $4.4 19. Dade-Behring (DADE) ... Stock Price Laggards Company - % Change 1. Medtronic, . 2. abraxis Bioscience, . 3. Procter & Gamble, . 4. 3M, . 5. St. Jude Medic...

Midwest life science stocks kept sizzling in Q2

... 17) Sigma-Aldrich (SIAL) $39.21 $41.52 $42.67 +9% $5.6 18) abraxis Bioscience (ABBI) $27.60 $26.71 $22.23 $3.6 19) Dade-Behri...8. Eli Lilly +7% Stock Price Laggards Company % Growth 1. abraxis Bioscience 2. AllScripts Healthcare 3. Walgreen 4. Proct...
Other Tags
(Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, 2014 and ... AAP, http://www.ohioaap.org ) is joining the National Highway Traffic ... talk to their teens and always set the rules before ... leading cause of death for U.S. teens. In 2012, there ... (42%) of those teen drivers were killed in crashes. While ...
(Date:10/20/2014)... October 20, 2014 Unveiled at the Sept. ... Direction Scorecard conservatively estimates member hospital ROI on membership dues ... dues, The Center provides $12.50 in value to member hospitals. ... Value – Member Dues)/Member Dues. , “This is the ... number and we think the methodology is really sound,” said ...
(Date:10/20/2014)... York, NY (PRWEB) October 20, 2014 ... be introduced in the U.S., has a lot to celebrate ... when our country recognizes the achievements and contributions of Americans ... the anniversary for Punzoné, and today it shares its favorite ... take a trip to Italy - even if it is ...
(Date:10/20/2014)... 20, 2014 Do you ever feel ... comes a wonderful app Metassessor for teachers, specialists and ... helped its client “Intervention Development LLC” to launch ... is designed for iOS 4.3 or later and is ... is optimized for iPhone 5. It is now available ...
(Date:10/19/2014)... 2014 The leading review website, ... ) and GreenGeeks are the best Dedicated Server ... those who want to buy high quality hosting ... The IT manager of Top10BestSEOHosting.com says, “We believe ... suppliers for everyone. A lot of the global ...
Breaking Medicine News(10 mins):Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2
(Date:10/14/2014)... A Mount Sinai-led research team has discovered a new kind ... or a cell that lines liver blood vessels, according to ... Reports . The existence of such a cell type contradicts ... the embryo, and may hold clues to origins of, and ... develop from a single cell into a complex being made ...
(Date:10/14/2014)... – A team of scientists led by researchers ... and the University of Miami Miller School of ... key genetic pathway underlying bipolar (manic depressive) disorder, ... for treating bipolar affective disorder, as well as ... new findings, published online this week in Nature ...
(Date:10/14/2014)... PA, October 14, 2014 – Over the past decades, ... of institutions to meet the needs of infants for ... of these infants to thrive. , Infancy ... development of the cortex. A generation of research suggests ... promote cortical development and cognitive function. In contrast, deprivation ...
Breaking Biology News(10 mins):Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3Institutional rearing may increase risk attention-deficit disorder 2
Other Contents